VANCOUVER, BC / ACCESSWIRE / July 14, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody" or the "Company"), announces that further to its news release dated June 10, 2022, the Company has...
VANCOUVER, BC / ACCESSWIRE / June 20, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that it is launching new genetic cancer tests to help...
VANCOUVER, BC / ACCESSWIRE / June 16, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that following its application for registration with...
Aligns With Company's Substantial U.K. Presence and Supports Its Growth Strategy
VANCOUVER, BC / ACCESSWIRE / May 26, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that, it has launched its core UK Health check which...
VANCOUVER, BC / ACCESSWIRE / May 25, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce its highest comprehensive profit of £0.10m and adjusted...
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
Announced that its subsidiary, PhytoVista Laboratories, has been granted a controlled drugs licence ...
VANCOUVER, BC / ACCESSWIRE / April 11, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that its subsidiary, PhytoVista Laboratories, has...
Announces that following the UK Food Standard Agencies publication of the Novel Foods approved list ...